These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36320059)
1. The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. Sullivan MK; Carrero JJ; Jani BD; Anderson C; McConnachie A; Hanlon P; Nitsch D; McAllister DA; Mair FS; Mark PB; Gasparini A BMC Med; 2022 Nov; 20(1):420. PubMed ID: 36320059 [TBL] [Abstract][Full Text] [Related]
2. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study. Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153 [TBL] [Abstract][Full Text] [Related]
3. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults. Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533 [TBL] [Abstract][Full Text] [Related]
4. Associations Between Kidney Histopathologic Lesions and Incident Cardiovascular Disease in Adults With Chronic Kidney Disease. Buckley LF; Schmidt IM; Verma A; Palsson R; Adam D; Shah AM; Srivastava A; Waikar SS JAMA Cardiol; 2023 Apr; 8(4):357-365. PubMed ID: 36884237 [TBL] [Abstract][Full Text] [Related]
5. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation. Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR; Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624 [TBL] [Abstract][Full Text] [Related]
6. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776 [TBL] [Abstract][Full Text] [Related]
7. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR. Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials. Clegg LE; Jing Y; Penland RC; Boulton DW; Hernandez AF; Holman RR; Vora J Diabetes Obes Metab; 2021 May; 23(5):1101-1110. PubMed ID: 33394543 [TBL] [Abstract][Full Text] [Related]
9. Increased vulnerability to COVID-19 in chronic kidney disease. Carlson N; Nelveg-Kristensen KE; Freese Ballegaard E; Feldt-Rasmussen B; Hornum M; Kamper AL; Gislason G; Torp-Pedersen C J Intern Med; 2021 Jul; 290(1):166-178. PubMed ID: 33452733 [TBL] [Abstract][Full Text] [Related]
10. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies. Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092 [TBL] [Abstract][Full Text] [Related]
11. Pain and Kidney Function Decline and Mortality: A Cohort Study of US Veterans. Ravel V; Ahmadi SF; Streja E; Sosnov JA; Kovesdy CP; Kalantar-Zadeh K; Chen JLT Am J Kidney Dis; 2016 Aug; 68(2):240-246. PubMed ID: 27108099 [TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) study. Corsonello A; Fabbietti P; Formiga F; Moreno-Gonzalez R; Tap L; Mattace-Raso F; Roller-Wirnsberger R; Wirnsberger G; Ärnlöv J; Carlsson AC; Weingart C; Freiberger E; Kostka T; Guligowska A; Gil P; Martinez SL; Melzer I; Yehoshua I; Lattanzio F; BMC Geriatr; 2020 Oct; 20(Suppl 1):350. PubMed ID: 33008303 [TBL] [Abstract][Full Text] [Related]
13. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697 [TBL] [Abstract][Full Text] [Related]
14. Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease. Sison SDM; Lin KJ; Najafzadeh M; Ko D; Patorno E; Bessette LG; Zakoul H; Kim DH J Am Geriatr Soc; 2023 Oct; 71(10):3179-3188. PubMed ID: 37354026 [TBL] [Abstract][Full Text] [Related]
15. Associations between modest reductions in kidney function and adverse outcomes in young adults: retrospective, population based cohort study. Hussain J; Grubic N; Akbari A; Canney M; Elliott MJ; Ravani P; Tanuseputro P; Clark EG; Hundemer GL; Ramsay T; Tangri N; Knoll GA; Sood MM BMJ; 2023 Jun; 381():e075062. PubMed ID: 37353230 [TBL] [Abstract][Full Text] [Related]
16. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Cohen JB; Yang W; Li L; Zhang X; Zheng Z; Orlandi P; Bansal N; Deo R; Lash JP; Rahman M; He J; Shafi T; Chen J; Cohen DL; Matsushita K; Shlipak MG; Wolf M; Go AS; Feldman HI; Am J Kidney Dis; 2022 Jan; 79(1):36-44.e1. PubMed ID: 34052355 [TBL] [Abstract][Full Text] [Related]
17. Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project. Carrero JJ; Trevisan M; Sood MM; Bárány P; Xu H; Evans M; Friberg L; Szummer K Clin J Am Soc Nephrol; 2018 Sep; 13(9):1314-1320. PubMed ID: 30030271 [TBL] [Abstract][Full Text] [Related]
18. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction. Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846 [TBL] [Abstract][Full Text] [Related]
19. Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation. Claxton JS; Chamberlain AM; Lutsey PL; Chen LY; MacLehose RF; Bengtson LGS; Alonso A Am J Med; 2020 Oct; 133(10):e554-e567. PubMed ID: 32320695 [TBL] [Abstract][Full Text] [Related]
20. The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease. Kim H; Park JT; Lee J; Jung JY; Lee KB; Kim YH; Yoo TH; Kang SW; Choi KH; Oh KH; Ahn C; Han SH; Atherosclerosis; 2021 Oct; 335():53-61. PubMed ID: 34571286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]